|
Bafna Pharmaceuticals Ltd.
|
Balance Sheet
|
|
|
You can view the
Balance Sheet
for the last 5 years.
|
Market Cap. (Rs.)
|
245.51 Cr.
|
P/BV
|
2.64
|
Book Value (Rs.)
|
39.34
|
|
52 Week High/Low (Rs.)
|
202/71
|
FV/ML
|
10/1
|
P/E(X)
|
59.13
|
|
Bookclosure
|
25/09/2024
|
EPS (Rs.)
|
1.76
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| No. of Equity Shares (in Lacs) | 23.66 | 236.56 | 236.56 | 186.56 | 186.56 |
| | | | | | |
| EQUITIES AND LIABILITIES | | | | | |
| SHAREHOLDER'S FUNDS | | | | | |
| Equity Share Capital | 2.37 | 23.66 | 23.66 | 18.66 | 18.66 |
| Total Share Capital | 2.37 | 23.66 | 23.66 | 18.66 | 18.66 |
| | | | | | |
| Reserves and Surplus | -6.61 | -4.60 | 14.27 | 20.01 | 39.10 |
| Total Reserves and Surplus | -6.61 | -4.60 | 14.27 | 20.01 | 39.10 |
| Money Received Against Share Warrants | 0.00 | 0.00 | 0.00 | 4.00 | 0.00 |
| Total Shareholders Funds | -4.24 | 19.06 | 37.93 | 42.67 | 57.75 |
| Equity Share Application Money | 55.36 | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.08 | -0.21 | -0.73 | -0.55 | 0.00 |
| | | | | | |
| NON-CURRENT LIABILITIES | | | | | |
| Long Term Borrowings | 3.02 | 22.99 | 23.25 | 39.01 | 35.17 |
| Deferred Tax Liabilities [Net] | 0.00 | 6.18 | 5.11 | 2.92 | 3.82 |
| Other Long Term Liabilities | 0.00 | 0.63 | 12.95 | 12.79 | 0.92 |
| Total Non-Current Liabilities | 3.02 | 29.80 | 41.31 | 54.72 | 39.91 |
| | | | | | |
| CURRENT LIABILITIES | | | | | |
| Short Term Borrowings | 0.00 | 23.24 | 23.29 | 43.37 | 45.31 |
| Trade Payables | 12.54 | 39.56 | 28.61 | 23.90 | 37.70 |
| Other Current Liabilities | 4.56 | 8.02 | 7.95 | 14.19 | 12.04 |
| Total Current Liabilities | 17.10 | 70.82 | 59.85 | 81.47 | 95.05 |
| | | | | | |
| Total Capital And Liabilities | 71.31 | 119.47 | 138.36 | 178.31 | 192.71 |
| | | | | | |
| ASSETS | | | | | |
| NON-CURRENT ASSETS | | | | | |
| Tangible Assets | 34.97 | 37.02 | 44.86 | 48.58 | 52.57 |
| Capital Work-In-Progress | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Assets | 35.18 | 37.02 | 44.86 | 48.58 | 52.57 |
| Goodwill On Consolidation | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Non-Current Investments | 0.00 | 0.00 | 0.00 | 16.90 | 16.90 |
| Other Non-Current Assets | 0.00 | 33.95 | 44.73 | 35.61 | 0.72 |
| Total Non-Current Assets | 35.22 | 71.00 | 89.62 | 101.12 | 70.22 |
| | | | | | |
| AssetMinorityInterest | 0.00 | 0.00 | 0.00 | 0.00 | 0.18 |
| | | | | | |
| CURRENT ASSETS | | | | | |
| Inventories | 11.41 | 9.28 | 10.67 | 16.74 | 16.38 |
| Trade Receivables | 6.03 | 24.83 | 24.28 | 53.78 | 80.85 |
| Cash And Cash Equivalents | 8.48 | 2.71 | 2.95 | 2.66 | 2.71 |
| Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 22.36 |
| OtherCurrentAssets | 10.17 | 11.64 | 10.83 | 4.01 | 0.00 |
| Total Current Assets | 36.10 | 48.47 | 48.74 | 77.18 | 122.30 |
| | | | | | |
| Total Assets | 71.31 | 119.47 | 138.36 | 178.31 | 192.71 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
| Contingent Liabilities | 0.00 | 0.00 | 0.46 | 0.29 | 1.64 |
| | | | | | |
| BONUS DETAILS | | | | | |
| Bonus Equity Share Capital | 0.54 | 5.43 | 5.43 | 5.43 | 5.43 |
| | | | | | |
| NON-CURRENT INVESTMENTS | | | | | |
| Non-Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 16.90 | 16.90 |
